| INTRODUCTION
Patent ductus arteriosus (PDA) is a common congenital heart defect in the dog. 1, 2 Considerable variability in PDA anatomy occurs among affected dogs, with a previous angiographic classification scheme consisting of 4 distinct phenotypes: type I, type IIa, type IIb, and type III. 3 Recent work suggests that type IV (multiple narrowings of the ampulla) and type V (other configurations) phenotypes should be added to the previous classification scheme, 4 with type IV being the same as the previously reported type D. 5, 6 Of these phenotypes, a type III PDA is described as having a tubular appearance with minimal to no tapering in ductal diameter before insertion into the pulmonary artery. 3 Identification of a type III PDA impacts treatment options, because this anatomy is not considered amenable to interventional procedures with devices such as the Amplatz canine duct occluder (ACDO; Infiniti Medical, LLC Haverford, Pennsylvania).
In many dogs with type III PDA anatomy, surgical ligation is
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performed to avoid device-related complications arising from inadequate device stability.
German Shepherd dogs (GSD) are predisposed to PDA, with a reported odds ratio of 5.2. 2 Among published studies of dogs with PDA where breed frequency is reported, GSD often are the most commonly represented purebred population. 5, [7] [8] [9] [10] In addition, this breed also is reportedly predisposed to type III PDA anatomy. The published evidence for this proposed predisposition ranges from comments regarding author experience 3 to individual cases of procedural abandonment in GSD because of type III PDA anatomy that resulted in easy dislodgement of an ACDO with gentle push/pull manipulation (n = 2). 11 Detailed description of the frequency of type III PDA anatomy in the GSD breed is lacking. In 3 previously published studies of dogs and 2 case reports that included angiographic descriptions of PDA anatomy, no type III morphology was identified despite 32 reported GSD included in these populations. 5, 9, [12] [13] [14] Our objective was to describe PDA anatomy and procedural outcome of all GSD that were diagnosed with PDA and received definitive treatment, either surgical ligation or device-based intervention, over a 10-year period. Additional information about minimal ductal diameter (MDD), ampulla diameter, reason for surgical ligation, baseline characteristics at presentation, and long-term follow-up was also evaluated. were last known to be alive.
| MATERIALS AND METHODS

| RESULTS
Twenty-eight GSD had definitive treatment for PDA during the study period. Twenty-two had PDA occlusion using an ACDO, whereas 6 had surgical ligation of their PDA. There were 16 females (57%), ) as the ampulla approaches the pulmonary ostium and an acute angle into the pulmonary artery resulting in a caudally directed contrast jet entering into the main pulmonary artery. Dog A also has a second narrowing of the mid-ampulla region consistent with type IV PDA anatomy. C, Transesophageal echocardiographic image corresponding to the angiogram labeled B, in which the PDA ampulla (*) substantially narrows, forms a brief tunnel, then turns acutely toward the pulmonary artery, with excessive tissue on the pulmonary artery side of the ostium. Images of this dog have previously been published. 4 AO, aorta; PA, pulmonary artery or TEE to better define anatomy in the other 3 dogs. Surgical ligation was successful in all 6 cases.
During TEE image review, 3 GSD with type II PDA anatomy also were noted to have an eccentric (not central) location of the pulmonary ostium relative to the ampulla of the PDA. On 2-dimensional TEE, this anatomy gives an appearance of the PDA ampulla being flat on 1 side and tapered on the other (Figure 2A ). Three-dimensional TEE confirms the eccentric position of the ostium ( Figure 2B ). Two of these 3 dogs were occluded successfully using an ACDO, but the proximal cup of the device did not assume a completely native shape after release because of the eccentric location of the ostium ( Figure 2E ). The PDA in the third dog was surgically ligated for reasons unrelated to anatomy. An eccentric pulmonary ostium was not appreciable on angiographic ( Figure 2C ) or transthoracic ( Figure 2D ) images in the dog presented in Figure 2 .
Ten of the GSD (35.7%) had concurrent congenital heart defects identified in addition to their PDA. These defects included subaortic 
| DISCUSSION
The data presented here suggest that GSD presenting with PDA may differ in several ways compared to previously published, all-breed data. Baseline characteristics in large cohorts of dogs with PDA consistently report a predisposition for females (73.1%-80%), a relatively young age at presentation (median, 5.1-7.0 months), infrequent arrhythmias (2.9%-15%), and an absence of clinical signs in the majority of cases (69%-73.8%). 8, 21 In our population of GSD, sex distribution was more balanced, with 57% of dogs being female. German
Shepherd dogs also were presented at an older age (median, 12.1 months) and were more likely to have reported clinical signs (50%) and arrhythmias (29%) at presentation.
In this population of GSD, concurrent congenital heart disease also was more prevalent (35.7%) than previous reports of only 8.8%-10%. 8, 21 The most common concurrent defect was SAS, with 9 dogs having increased transaortic velocities ranging between 2.9 and Comparison of MDD in GSD versus other dogs is difficult, given the retrospective nature of our study and the variability in imaging modalities used for MDD measurements in previous work. Despite these limitations, some useful comparisons can be drawn. In 1 population of 112 dogs with PDA, MDD was measured by TEE, TTE, or angiography, depending on the patient, and resulted in a median MDD of 2.2 mm (range, 1.0-8.0 mm). 24 In another population of 246 dogs, MDD was measured angiographically in all cases and resulted in a median MDD of 2.5 mm (range, 1.0-9.5 mm). 3 In the GSD reported here, median MDD was 4.4-4.9 mm depending upon the imaging modality used, with an overall range of 1.6-9.2 mm. Of the GSD with an available MDD-A, the median was 4.5 mm. These comparisons suggest that median MDD in GSD does seem to be larger than reported median MDD in all breed populations. This conclusion is further supported by 3 prior cases of very large MDD deemed too large for successful occlusion with the largest ACDO or vascular plug in GSD in the absence of type III anatomy. 11, 24 Additionally, median ACDO size deployed in a mixed population cohort of 152 dogs from our institution was size 6, 10 whereas the median ACDO size deployed in the GSD of this study was size 8.
Accurate measurement of MDD is essential for adequate device sizing, appropriate procedural selection, and subsequent procedural success. The recommended method for ACDO sizing is to select a device with a waist that is twice the diameter of the MDD. 25 Any dog with an MDD-TTE >7 mm on initial screening has the potential to require surgi- Limitations of our study are largely related to its retrospective nature. Missing data for different imaging modalities in the same patient limited the utility of statistical comparison for different measurements of MDD and also precluded our ability to definitively confirm PDA anatomy in 4 cases. In addition, the anatomy that was confirmed in this cohort reflects the GSD population and genetic lines within the referral region of our institution and may not reflect larger populations within the United States or in other parts of the world. A prospective, anatomic study comparing TEE, TTE, and angiographic imaging of a larger, more geographically diverse, GSD cohort would be useful.
In summary, GSD with PDA in this population were more likely to present older, have clinical signs at the time of diagnosis, and have more frequent concurrent congenital heart defects and arrhythmias than other breeds. Although a female predominance was noted, it was less pronounced than in previous reports for all-breed populations.
German Shepherds in this cohort most commonly had type II PDA anatomy, with rare instances of type IV and type V anatomy. Despite a tendency for GSD to have a larger median MDD than previously reported with all-breed data, in the majority of cases, tapering ductal anatomy allowed for PDA occlusion by ACDO deployment. Occlusion or ligation of the PDA offered a clinically relevant survival benefit and resulted in an overall median survival time (9.6 years) consistent with a relatively normal life span for GSD. Additional imaging with TEE may be required for optimal procedural planning in this breed.
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